CTOs on the Move

FibroGen

www.fibrogen.com

 
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.fibrogen.com
  • 409 Illinois St
    San Francisco, CA USA 94158
  • Phone: 415.978.1200

Executives

Name Title Contact Details
Curtis Golston
Director IT Operations Profile

Funding

FibroGen raised $126.02M on 07/09/2016

Similar Companies

Wellvana

Founded in 2019, Wellvana is a company designed to support independent physicians and help them thrive in their transition to value-based care. With a mission of creating a national footprint of high performing, locally narrow networks, Wellvana aims to deliver high quality and highly efficient healthcare services while contracting on behalf of and migrating physicians towards risk-based reimbursement methodologies. Wellvana provides the resources, experience, and leadership to allow physicians to practice effectively, achieve work life balance, and benefit from risk-based revenue models, while respecting cultural, regional, and individual practice uniqueness.

canfield scientific inc

canfield scientific inc is a Fairfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Hope Heart Institute

The Hope Heart Institute is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Massive Bio

Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.

Hartford Neurology

Hartford Neurology is a Bloomfield, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.